IOL Chemicals & Pharmaceuticals Ltd

iolcp.com BSE: 524164 NSE : IOLCP
About [ edit ]

IOL Chemicals & Pharmaceuticals is engaged in the manufacturing and selling of APIs / bulk drugs and specialty chemicals. The company caters to both domestic and international market.

Some of the APIs produced are ibuprofen, metformin hydrochloride, lamotrigine, fenofibrate, and clopidogrel bi sulphate for use in various therapeutic categories, including pain management, anti-diabetic, anti-hypertensive, anti-convulsant, anti-cholesterol, anti-platelet, etc. It also provides specialty industrial chemicals, which include ethyl acetate, iso butyl benzene, acetyl chloride etc.

IOL is an associate of the Trident Group, India #

Key Points [ edit ]
Website BSE NSE
  • Market Cap ₹ 3,636 Cr.
  • Current Price ₹ 620
  • High / Low ₹ 899 / 304
  • Stock P/E 7.91
  • Book Value ₹ 186
  • Dividend Yield 0.65 %
  • ROCE 68.9 %
  • ROE 56.9 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 49.30% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 53.19%
  • Company's median sales growth is 17.03% of last 10 years

Cons

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020
288 362 423 478 422 493 449 511 441 460 533 513
255 322 348 343 265 348 316 352 305 308 362 356
Operating Profit 32 40 75 136 157 145 133 160 137 152 171 157
OPM % 11% 11% 18% 28% 37% 29% 30% 31% 31% 33% 32% 31%
Other Income 3 4 6 1 2 3 3 4 5 6 4 8
Interest 15 16 14 13 9 8 6 4 3 2 1 1
Depreciation 8 8 8 8 8 9 9 9 9 9 10 10
Profit before tax 13 20 59 115 143 131 121 151 130 147 165 154
Tax % 10% 27% 35% 29% 29% 35% 28% 35% 31% 13% 23% 25%
Net Profit 11 14 38 82 102 85 88 98 90 128 127 115
EPS in Rs 2.04 2.56 6.83 14.63 17.87 15.00 15.42 17.23 15.87 21.73 21.63 19.56
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 TTM
301 347 387 471 482 564 385 580 711 983 1,685 1,894 1,948
268 309 319 402 392 468 373 529 608 863 1,276 1,321 1,331
Operating Profit 33 39 68 69 89 96 11 51 102 120 410 574 618
OPM % 11% 11% 18% 15% 18% 17% 3% 9% 14% 12% 24% 30% 32%
Other Income 3 1 2 2 3 1 1 1 1 6 10 16 23
Interest 15 15 37 43 57 60 59 61 68 64 51 21 7
Depreciation 10 10 24 24 31 32 29 30 30 30 32 36 38
Profit before tax 11 15 9 4 3 5 -75 -39 6 31 336 533 596
Tax % -14% 32% 32% -25% 46% 35% 12% -4% 21% 12% 30% 32%
Net Profit 13 10 6 5 2 3 -67 -40 5 28 237 361 460
EPS in Rs 6.99 4.41 2.40 1.85 0.61 1.15 -13.99 -7.12 0.83 4.93 41.61 63.51 78.79
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 5%
Compounded Sales Growth
10 Years:18%
5 Years:38%
3 Years:39%
TTM:4%
Compounded Profit Growth
10 Years:43%
5 Years:49%
3 Years:323%
TTM:23%
Stock Price CAGR
10 Years:32%
5 Years:40%
3 Years:84%
1 Year:66%
Return on Equity
10 Years:22%
5 Years:38%
3 Years:53%
Last Year:57%

Balance Sheet

Figures in Rs. Crores

Corporate actions
Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Sep 2020
23 28 31 31 31 49 48 56 56 56 57 57 59
Reserves 79 116 140 142 142 160 154 129 132 160 408 747 1,036
Borrowings 247 269 337 394 400 357 400 453 447 422 284 56 25
75 100 100 124 159 195 100 135 182 214 193 315 334
Total Liabilities 420 508 603 687 727 741 702 772 817 852 942 1,176 1,454
123 373 351 462 430 411 403 400 374 406 412 469 495
CWIP 187 1 57 12 32 33 4 4 21 7 27 19 20
Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
109 135 195 213 265 297 295 369 422 439 503 687 939
Total Assets 420 508 603 687 727 741 702 772 817 852 942 1,176 1,454

Cash Flows

Figures in Rs. Crores

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
16 31 24 55 53 78 -47 18 83 120 273 471
-167 -67 -69 -87 -18 -12 -5 -27 -23 -50 -63 -185
154 35 59 23 -32 -66 50 9 -60 -70 -197 -272
Net Cash Flow 3 -0 13 -9 3 1 -2 -0 1 -1 13 15

Ratios

Figures in Rs. Crores

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
ROCE % 10% 8% 10% 9% 11% 11% -3% 4% 12% 15% 56% 69%
Debtor Days 31 32 29 17 27 32 31 55 58 54 43 54
Inventory Turnover 5.58 4.62 3.32 3.01 2.34 2.33 1.62 2.09 2.10 3.15 5.61 6.01

Shareholding Pattern

Numbers in percentages

Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021
41.19 41.19 41.19 41.89 41.89 41.89 41.89 41.89 43.69 43.69 43.69 43.69
0.00 0.04 0.16 1.76 1.46 1.75 1.32 2.61 6.47 6.40 7.77 5.96
0.02 0.03 0.10 0.26 0.57 0.38 0.43 0.26 0.25 0.02 0.06 0.06
58.80 58.74 58.55 56.09 56.07 55.98 56.36 55.24 49.59 49.89 48.48 50.29

Documents

Recent announcements


View all

Annual reports

Credit ratings

Concalls